scholarly article | Q13442814 |
P356 | DOI | 10.4172/2161-0495.1000181 |
P8608 | Fatcat ID | release_iv35pskpyzemtliaxbwdacs3du |
P932 | PMC publication ID | 4060629 |
P698 | PubMed publication ID | 24949227 |
P5875 | ResearchGate publication ID | 261761946 |
P50 | author | Ruben K. Dagda | Q57708033 |
P2093 | author name string | Eppie D Rael | |
Sardar E Gasanov | |||
P2860 | cites work | Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells | Q23910949 |
Cancer cell injury by cytotoxins from cobra venom is mediated through lysosomal damage | Q24534905 | ||
Therapeutic potential of snake venom in cancer therapy: current perspectives | Q24633814 | ||
Two forms of cytotoxin II (cardiotoxin) from Naja naja oxiana in aqueous solution: spatial structures with tightly bound water molecules | Q27619247 | ||
Elucidation of the solution structure of cardiotoxin analogue V from the Taiwan cobra (Naja naja atra)-Identification of structural features important for the lethal action of snake venom cardiotoxins | Q27622353 | ||
Structural basis of membrane-induced cardiotoxin A3 oligomerization | Q27640836 | ||
Amino acid sequence and crystal structure of BaP1, a metalloproteinase from Bothrops asper snake venom that exerts multiple tissue-damaging activities | Q27642198 | ||
Crystal structures of catrocollastatin/VAP2B reveal a dynamic, modular architecture of ADAM/adamalysin/reprolysin family proteins | Q27644715 | ||
The three-dimensional structure of bothropasin, the main hemorrhagic factor from Bothrops jararaca venom: insights for a new classification of snake venom metalloprotease subgroups | Q27652381 | ||
Interfacial catalysis: the mechanism of phospholipase A2 | Q27681640 | ||
Crystal structure of cobra-venom phospholipase A2 in a complex with a transition-state analogue | Q27681641 | ||
Inflammatory events induced by Lys-49 and Asp-49 phospholipases A2 isolated from Bothrops asper snake venom: role of catalytic activity | Q45246214 | ||
Wound exudate as a proteomic window to reveal different mechanisms of tissue damage by snake venom toxins | Q45355910 | ||
Ultrastructural evidence for the uptake of a neurotoxic snake venom phospholipase A2 into mammalian motor nerve terminals. | Q45920271 | ||
Backbone flexibility controls the activity and specificity of a protein-protein interface: specificity in snake venom metalloproteases | Q46083143 | ||
Isolation of two hemorrhagic toxins from Crotalus basiliscus basiliscus (Mexican west coast rattlesnake) venom and their effect on blood clotting and complement | Q46606934 | ||
Activation of cellular functions in macrophages by venom secretory Asp-49 and Lys-49 phospholipases A(2). | Q46638842 | ||
Preclinical assessment of the efficacy of a new antivenom (EchiTAb-Plus-ICP) for the treatment of viper envenoming in sub-Saharan Africa | Q46673260 | ||
Snake venomics of African spitting cobras: toxin composition and assessment of congeneric cross-reactivity of the pan-African EchiTAb-Plus-ICP antivenom by antivenomics and neutralization approaches | Q46715019 | ||
Purification and functional characterization of bothrojaractivase, a prothrombin-activating metalloproteinase isolated from Bothrops jararaca snake venom. | Q46762342 | ||
Glycosphingolipid-facilitated membrane insertion and internalization of cobra cardiotoxin. The sulfatide.cardiotoxin complex structure in a membrane-like environment suggests a lipid-dependent cell-penetrating mechanism for membrane binding polypept | Q46786462 | ||
Restoration of enzymatic activity in a Ser-49 phospholipase A2 homologue decreases its Ca(2+)-independent membrane-damaging activity and increases its toxicity | Q46957861 | ||
Central Asian cobra venom cytotoxins-induced aggregation, permeability and fusion of liposomes | Q47908498 | ||
Chemistry and functional distribution of sulfoglycolipids | Q47926761 | ||
Cobra venom cardiotoxin (cytotoxin) isoforms and neurotoxin: comparative potency of protein kinase C inhibition and cancer cell cytotoxicity and modes of enzyme inhibition | Q48321312 | ||
Pre-clinical and preliminary dose-finding and safety studies to identify candidate antivenoms for treatment of envenoming by saw-scaled or carpet vipers (Echis ocellatus) in northern Nigeria. | Q50607136 | ||
A phospholipase A2-activating protein (PLAP) stimulates human neutrophil aggregation and release of lysosomal enzymes, superoxide, and eicosanoids. | Q50888135 | ||
Binding of cardiotoxin analogue III from Formosan cobra venom to FL cells. | Q50907805 | ||
Intraspecies variation in the venom of the rattlesnake Crotalus simus from Mexico: different expression of crotoxin results in highly variable toxicity in the venoms of three subspecies. | Q50945141 | ||
Novel insights into capillary vessel basement membrane damage by snake venom hemorrhagic metalloproteinases: a biochemical and immunohistochemical study. | Q52574459 | ||
Accelerated evolution and molecular surface of venom phospholipase A2 enzymes | Q56902331 | ||
Crystal structure of bee-venom phospholipase A2 in a complex with a transition-state analogue | Q27681643 | ||
First structure of a snake venom metalloproteinase: a prototype for matrix metalloproteinases/collagenases | Q27731442 | ||
Surface exposure of phosphatidylserine in pathological cells | Q28239340 | ||
Phospholipase A2 biochemistry | Q28297979 | ||
Hemorrhagic toxins from western diamondback rattlesnake (Crotalus atrox) venom: isolation and characterization of five toxins and the role of zinc in hemorrhagic toxin e | Q28298436 | ||
Structural considerations of the snake venom metalloproteinases, key members of the M12 reprolysin family of metalloproteinases. | Q30436990 | ||
Interaction of hemorrhagic metalloproteinases with human .alpha.2-macroglobulin | Q30441381 | ||
Insights into and speculations about snake venom metalloproteinase (SVMP) synthesis, folding and disulfide bond formation and their contribution to venom complexity | Q30446200 | ||
A prothrombin activator from Bothrops erythromelas (jararaca-da-seca) snake venom: characterization and molecular cloning | Q30847418 | ||
Fusion of sphingomyelin vesicles induced by proteins from Taiwan cobra (Naja naja atra) venom. Interactions of zwitterionic phospholipids with cardiotoxin analogues. | Q30915389 | ||
Factor X activator from Vipera lebetina snake venom, molecular characterization and substrate specificity | Q32042354 | ||
Three-finger alpha-neurotoxins and the nicotinic acetylcholine receptor, forty years on. | Q33197124 | ||
Factor X activator from Vipera lebetina venom is synthesized from different genes | Q33207388 | ||
Naturally occurring disulfide-bound dimers of three-fingered toxins: a paradigm for biological activity diversification | Q33326504 | ||
Excitement ahead: structure, function and mechanism of snake venom phospholipase A2 enzymes | Q33339804 | ||
Molecular models of the Mojave rattlesnake (Crotalus scutulatus scutulatus) venom metalloproteinases reveal a structural basis for differences in hemorrhagic activities | Q33726161 | ||
Anionic phospholipids, interfacial binding and the regulation of cell functions | Q33817222 | ||
Antivenomic assessment of the immunological reactivity of EchiTAb-Plus-ICP, an antivenom for the treatment of snakebite envenoming in sub-Saharan Africa | Q33880753 | ||
Snake cytotoxins bind to membranes via interactions with phosphatidylserine head groups of lipids | Q33895247 | ||
The fusogenic properties of the cytotoxins of cobra venom in a model membrane system | Q33915067 | ||
Fibrinolytic enzymes from the venoms of Agkistrodon contortrix contortrix and Crotalus basiliscus basiliscus: cleavage site specificity towards the alpha-chain of fibrin | Q34333830 | ||
Cloning and expression of a membrane receptor for secretory phospholipases A2. | Q34348680 | ||
Phosphatidylserine, a death knell | Q34355981 | ||
Equivalent effects of snake PLA2 neurotoxins and lysophospholipid-fatty acid mixtures | Q34474542 | ||
Idiopathic Parkinson's disease: a review of clinical types and pathology | Q34503526 | ||
Differential myotoxic and cytotoxic activities of pre-synaptic neurotoxins from Papuan taipan (Oxyuranus scutellatus) and Irian Jayan death adder (Acanthophis rugosus) venoms | Q34546019 | ||
Purification and characterization of a fibrinolytic enzyme from venom of the southern copperhead snake (Agkistrodon contortrix contortrix). | Q34871200 | ||
Snake and snail toxins acting on nicotinic acetylcholine receptors: fundamental aspects and medical applications | Q35637410 | ||
Inflammatory effects of snake venom myotoxic phospholipases A2. | Q35690586 | ||
Nerve terminal damage by beta-bungarotoxin: its clinical significance | Q35745331 | ||
Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia. | Q35979479 | ||
Snake venom fibrin(ogen)olytic enzymes | Q36121437 | ||
Structures and functions of snake venom CLPs (C-type lectin-like proteins) with anticoagulant-, procoagulant-, and platelet-modulating activities | Q36143064 | ||
The intriguing world of prothrombin activators from snake venom | Q36143075 | ||
Snake venom cardiotoxins and bee venom melittin activate phospholipase C activity in primary cultures of skeletal muscle | Q44020379 | ||
Action of two phospholipases A2 purified from Bothrops alternatus snake venom on macrophages. | Q44089638 | ||
Fibrolase, an active thrombolytic enzyme in arterial and venous thrombosis model systems. | Q44634811 | ||
An unusual phospholipase A₂ from puff adder Bitis arietans venom--a novel blocker of nicotinic acetylcholine receptors | Q44918163 | ||
Isolation and characterization of a cytotoxin P4 from the venom of Naja nigricollis nigricollis preferentially active on tumor cells | Q44945745 | ||
Mojave toxin in venom of Crotalus helleri (Southern Pacific Rattlesnake): molecular and geographic characterization | Q45121013 | ||
Comparative study of structure and activity of cytotoxins from venom of the cobras Naja oxiana, Naja kaouthia, and Naja haje. | Q45139933 | ||
Structural basis of citrate-dependent and heparan sulfate-mediated cell surface retention of cobra cardiotoxin A3. | Q45182274 | ||
Binding of Nucleotide Triphosphates to Cardiotoxin Analogue II from the Taiwan Cobra Venom (Naja naja atra) | Q57836437 | ||
Mojave rattlesnakes (Crotalus scutulatus scutulatus) lacking the acidic subunit DNA sequence lack Mojave toxin in their venom | Q61847177 | ||
Calcium Influx and Mitochondrial Alterations at Synapses Exposed to Snake Neurotoxins or Their Phospholipid Hydrolysis Products | Q63408246 | ||
Prothrombin activation induced by ecarin - A prothrombin converting enzyme from echis carinatus venom | Q66911360 | ||
Binding of cytotoxin P4 from Naja nigricollis nigricollis to B16F10 melanoma and WEHI-3B leukemia cells | Q67570041 | ||
Intermembrane exchange of lipids induced by cobra venom cytotoxins | Q68079566 | ||
Fibrinolytic proteases in snake venoms | Q68405870 | ||
Identification and purification of a very high affinity binding protein for toxic phospholipases A2 in skeletal muscle | Q68461520 | ||
alpha 2-macroglobulin traps a proteinase in the midregion of its arms. An immunoelectron microscopic study | Q69052964 | ||
Cobra cardiotoxins. Purification, effects on skeletal muscle and structure/activity relationships [published errtum appears in Eur J Biochem 1988 Feb 1;171(3):727] | Q69056700 | ||
Identification and properties of very high affinity brain membrane-binding sites for a neurotoxic phospholipase from the taipan venom | Q69351278 | ||
[Interaction of cobra venom cytotoxin with oriented phospholipid multi-bilayers] | Q70142125 | ||
A new class of phospholipases A2 with lysine in place of aspartate 49. Functional consequences for calcium and substrate binding | Q70507006 | ||
Membrane disintegration and hemolysis of human erythrocytes by snake venom cardiotoxin (a membrane-disruptive polypeptide) | Q70612336 | ||
Isolation and characterization of carinactivase, a novel prothrombin activator in Echis carinatus venom with a unique catalytic mechanism | Q71049025 | ||
Cellular and mitochondrial changes induced in the structure of murine skeletal muscle by crotoxin, a neurotoxic phospholipase A2 complex | Q71341420 | ||
Dissociation of enzymatic activity from lethality and pharmacological properties by carbamylation of lysines in Naja nigricollis and Naja naja atra snake venom phospholipases A2 | Q71576268 | ||
Phospholipase A2 and cobra venom cytotoxin Vc5 interactions and membrane structure | Q71627404 | ||
In vitro evaluation of Pyrularia thionin-anti-CD5 immunotoxin | Q71707790 | ||
Myotoxic activity of the toxic phospholipase, notexin, from the venom of the Australian tiger snake | Q71866621 | ||
Refined 2.0 A X-ray crystal structure of the snake venom zinc-endopeptidase adamalysin II. Primary and tertiary structure determination, refinement, molecular structure and comparison with astacin, collagenase and thermolysin | Q72003150 | ||
Evidence that meizothrombin is an intermediate product in the clotting of whole blood | Q72294564 | ||
Studies on the complex between human and Crotalus adamanteus proteinase II. Release of active proteinase from the complex | Q72624372 | ||
Modulation of phospholipase A2 activity by membrane-active peptides on liposomes of different phospholipid composition | Q72630147 | ||
Hemorrhagic and Mojave toxins in the venoms of the offspring of two Mojave rattlesnakes (Crotalus scutulatus scutulatus) | Q72708681 | ||
Thrombolytic effects of recombinant fibrolase or APSAC in a canine model of carotid artery thrombosis | Q72791775 | ||
Modification of phospholipid membrane structure by the plant toxic peptide Pyrularia thionin | Q72961268 | ||
The amino acid region 115-119 of ammodytoxins plays an important role in neurotoxicity | Q73067326 | ||
Cobra venom cytotoxin free of phospholipase A2 and its effect on model membranes and T leukemia cells | Q73107630 | ||
Differences in fibrinolysis and complement inactivation by venom from different northern blacktailed rattlesnakes (Crotalus molossus molossus) | Q73303285 | ||
Structures of heparin-derived tetrasaccharide bound to cobra cardiotoxins: heparin binding at a single protein site with diverse side chain interactions | Q80764913 | ||
Hemorrhagic activity of the vascular apoptosis-inducing proteins VAP1 and VAP2 from Crotalus atrox | Q81703232 | ||
Invited commentary. Efficacy and safety of alfimeprase in patients with acute peripheral arterial occlusion (PAO) | Q83144308 | ||
Alfimeprase for the treatment of acute peripheral arterial occlusion | Q94696833 | ||
Practical applications of snake venom toxins in haemostasis | Q36143100 | ||
Snake venom metalloproteases--structure and function of catalytic and disintegrin domains | Q36376643 | ||
Phosphatidic acid- and phosphatidylserine-binding proteins | Q36453653 | ||
Snakebite nephropathy | Q36609884 | ||
cDNA cloning and deduced amino acid sequence of prothrombin activator (ecarin) from Kenyan Echis carinatus venom | Q36715062 | ||
Mitochondrial proteolipids | Q36758496 | ||
Serpins in thrombosis, hemostasis and fibrinolysis | Q36884340 | ||
Genetic Basis for Variation of Metalloproteinase-Associated Biochemical Activity in Venom of the Mojave Rattlesnake (Crotalus scutulatus scutulatus). | Q37101222 | ||
Three-dimensional domain architecture of the ADAM family proteinases | Q37244846 | ||
The ins and outs of phospholipid asymmetry in the plasma membrane: roles in health and disease | Q37455021 | ||
Snakebite envenomation and death in the developing world. | Q37502969 | ||
Enzymatic toxins from snake venom: structural characterization and mechanism of catalysis | Q37862381 | ||
Inhibition of phospholipase A2 by uteroglobin and antiflammin peptides | Q37868131 | ||
Snake venom metalloproteinases: structure, function and relevance to the mammalian ADAM/ADAMTS family proteins | Q37870424 | ||
Immune response towards snake venoms | Q37913413 | ||
Fibrolase: trials and tribulations | Q37954287 | ||
Snake venom metalloproteinases | Q38045664 | ||
Structure and dynamics of cardiotoxins | Q38045944 | ||
Phospholipases A2: unveiling the secrets of a functionally versatile group of snake venom toxins | Q38048397 | ||
Cobra cardiotoxins: membrane interactions and pharmacological potential | Q38158055 | ||
Active-site mutagenesis of a Lys49-phospholipase A2: biological and membrane-disrupting activities in the absence of catalysis | Q38292301 | ||
Neutralizing interaction between heparins and myotoxin II, a lysine 49 phospholipase A2 from Bothrops asper snake venom. Identification of a heparin-binding and cytolytic toxin region by the use of synthetic peptides and molecular modeling. | Q38302217 | ||
A model to explain the pharmacological effects of snake venom phospholipases A2. | Q38664430 | ||
The anticancer effect of cytotoxin 1 from Naja atra Cantor venom is mediated by a lysosomal cell death pathway involving lysosomal membrane permeabilization and cathepsin B release | Q39147019 | ||
Acute renal failure after Crotalus durissus snakebite: a prospective survey on 100 patients | Q39357094 | ||
Structure and pharmacology of elapid cytotoxins | Q39628032 | ||
Proteinase K-resistant alpha-synuclein is deposited in presynapses in human Lewy body disease and A53T alpha-synuclein transgenic mice | Q39722484 | ||
Efficacy and safety of alfimeprase in patients with acute peripheral arterial occlusion (PAO). | Q39905616 | ||
Role of glycosphingolipid conformational change in membrane pore forming activity of cobra cardiotoxin | Q40071561 | ||
Amphiphilic beta-sheet cobra cardiotoxin targets mitochondria and disrupts its network | Q40416049 | ||
Alpha-synuclein up-regulates expression of caveolin-1 and down-regulates extracellular signal-regulated kinase activity in B103 neuroblastoma cells: role in the pathogenesis of Parkinson's disease | Q40642550 | ||
Possible mechanisms of action of cobra snake venom cardiotoxins and bee venom melittin | Q40830596 | ||
Three-dimensional structures of neurotoxins and cardiotoxins | Q40847242 | ||
Snake venom cardiotoxins-structure, dynamics, function and folding | Q40872119 | ||
Heart and T-lymphocyte cell surfaces both exhibit positive cooperativity in binding a membrane-lytic toxin | Q41222180 | ||
Contribution of bee venom phospholipase A2 contamination in melittin fractions to presumed activation of tissue phospholipase A2. | Q41241341 | ||
Characterization of the inactive fragment resulting from limited proteolysis of human alpha1-proteinase inhibitor by Crotalus adamanteus proteinase II. | Q41629227 | ||
Membrane interactions of amphiphilic polypeptides mastoparan, melittin, polymyxin B, and cardiotoxin. Differential inhibition of protein kinase C, Ca2+/calmodulin-dependent protein kinase II and synaptosomal membrane Na,K-ATPase, and Na+ pump and di | Q41695494 | ||
Pathogenesis of myonecrosis induced by crude venom and a myotoxin of Bothrops asper | Q42459179 | ||
Pathogenesis of hemorrhage induced by bilitoxin, a hemorrhagic toxin isolated from the venom of the common cantil (Agkistrodon bilineatus bilineatus). | Q42481849 | ||
Pathogenesis of hemorrhage induced by hemorrhagic proteinase IV from timber rattlesnake (Crotalus horridus horridus) venom | Q42517098 | ||
Mass spectrometry analysis of the phospholipase A(2) activity of snake pre-synaptic neurotoxins in cultured neurons. | Q43284922 | ||
Involvement of specific integrins in apoptosis induced by vascular apoptosis-inducing protein 1. | Q43872597 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | snake venom | Q424200 |
snake | Q2102 | ||
pharmacology | Q128406 | ||
P304 | page(s) | 1000181 | |
P577 | publication date | 2014-01-25 | |
P1433 | published in | Journal of clinical toxicology | Q26839864 |
P1476 | title | Snake Venom Cytotoxins, Phospholipase A2s, and Zn(2+)-dependent Metalloproteinases: Mechanisms of Action and Pharmacological Relevance | |
P478 | volume | 4 |
Q90090437 | A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology |
Q36246909 | Antitumor potential of the myotoxin BthTX-I from Bothrops jararacussu snake venom: evaluation of cell cycle alterations and death mechanisms induced in tumor cell lines |
Q55309450 | Attenuation of autophagy impacts on muscle fibre development, starvation induced stress and fibre regeneration following acute injury. |
Q60467280 | Cell surface nucleolin interacts with and internalizes Bothrops asper Lys49 phospholipase A and mediates its toxic activity |
Q64118819 | Cobra Cardiotoxin Targets Mitochondria to Disrupt Mitochondrial Membrane Structure and Function |
Q37741859 | Comparative venom gland transcriptomics of Naja kaouthia (monocled cobra) from Malaysia and Thailand: elucidating geographical venom variation and insights into sequence novelty |
Q90291054 | Cytotoxic effects of Pseudocerastes persicus venom and its HPLC fractions on lung cancer cells |
Q64249393 | Exploring the Diversity and Novelty of Toxin Genes in , the Equatorial Spitting Cobra from Malaysia through Venom-Gland Transcriptomics |
Q52666841 | First Look at the Venom of Naja ashei. |
Q47678523 | Impact of membrane partitioning on the spatial structure of an S-type cobra cytotoxin. |
Q28396771 | Naja naja oxiana Cobra Venom Cytotoxins CTI and CTII Disrupt Mitochondrial Membrane Integrity: Implications for Basic Three-Fingered Cytotoxins |
Q45074082 | Non-bilayer structures in mitochondrial membranes regulate ATP synthase activity |
Q54981985 | Non-neurotoxic activity of Malayan krait (Bungarus candidus) venom from Thailand. |
Q89594363 | Pathogenesis of local necrosis induced by Naja atra venom: Assessment of the neutralization ability of Taiwanese freeze-dried neurotoxic antivenom in animal models |
Q50133759 | Pharmacokinetics of Snake Venom. |
Q28547272 | Progressive Hemorrhage and Myotoxicity Induced by Echis carinatus Venom in Murine Model: Neutralization by Inhibitor Cocktail of N,N,N',N'-Tetrakis (2-Pyridylmethyl) Ethane-1,2-Diamine and Silymarin |
Q93353959 | Quantitative Characterization of the Hemorrhagic, Necrotic, Coagulation-Altering Properties and Edema-Forming Effects of Zebra Snake (Naja nigricincta nigricincta) Venom |
Q64077092 | RNA-seq analysis of the salivary glands and midgut of the Argasid tick Ornithodoros rostratus |
Q39120708 | Regulation of muscle growth and regeneration by the immune system |
Q48507956 | Revisiting the Therapeutic Potential of Bothrops jararaca Venom: Screening for Novel Activities Using Connectivity Mapping |
Q38849314 | Snake venom toxins: toxicity and medicinal applications |
Q90820606 | TFPR1 acts as an immune regulator and an efficient adjuvant for proteins and peptides by activating immune cells, primarily through TLR2 |
Q58549726 | The Venom of Spectacled Cobra (Elapidae: ): Study from Distinct Geographical Origins in Sri Lanka |
Q28643191 | The venomous cocktail of the vampire snail Colubraria reticulata (Mollusca, Gastropoda) |
Q58647020 | Toxin synergism in snake venoms |
Q39858672 | Ultrasound findings in 42 patients with cytotoxic tissue damage following bites by South African snakes |
Q95840702 | Unity Makes Strength: Exploring Intraspecies and Interspecies Toxin Synergism between Phospholipases A2 and Cytotoxins |
Search more.